Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH
View:
Post by Pandora on Sep 15, 2022 7:01pm

Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH

Non-final rejection normally means the examiner did not like some things and now the Company has 90 days to respond.

USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES

09/15/2022 CTNF Non-Final Rejection 19 Preview DOCX / PDF / XML
09/15/2022 892 List of references cited by examiner 1 Preview PDF
09/15/2022 SRFW Search information including classification, databases and other search related notes 1 Preview PDF
09/15/2022 1449 List of References cited by applicant and considered by examiner 5 Preview PDF
09/15/2022 SRNT Examiner's search strategy and results 2 Preview PDF
09/15/2022 SRNT Examiner's search strategy and results 2 Preview PDF
09/15/2022 NPL Non Patent Literature 19 Preview    
09/15/2022 SRNT Examiner's search strategy and results 2 Preview PDF
09/15/2022 SRNT Examiner's search strategy and results

28515 - C/O AH PATENT DEPARTMENT
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD.
BLDG. 500
DULUTH, GA
UNITED STATES
Comment by lscfa on Sep 16, 2022 12:19am
Not a Sirona application... https://patentimages.storage.googleapis.com/d3/87/1a/80baa6f657f6d5/WO2021165177A1.pdf
Comment by biorun on Sep 16, 2022 9:18am
Thanks Pandora for following this stuff for the rest of us. Interestingly, the September update noted the successful and significant extension of the anti-aging platform. I presume that is through modification of the patent to remain current for much longer periods of time. I have confirmed with the company on several occasions that Sirona TFC-039 SGLT2 is at the centre of the pets deal, and I ...more  
Comment by Pareto8020 on Sep 16, 2022 2:20pm
You would think with the Allergan "MEGA" deal, pending clinical trial for their Botox killer (according to HV), pending deal for in the feline diabetes realm, new application of their SGLT2, management reorg, + SBM having to post their financials in a couple weeks which should disclose the upfront payment so big it made Howard smile that the shareprice would be ramping up in price and ...more  
Comment by PeterG on Sep 16, 2022 2:46pm
Pareto, so true and nothing really to add.
Sirona Biochem Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities